Gefitinib Impurity 30 | CAS 675126-27-9 - Request Quote
Gefitinib Impurity 30
| SZ CAT No: | SZ-G018049 |
| CAS No | 675126-27-9 |
| Mol.F. | C15H21N3O3 |
| Mol.Wt. | 291.4 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1561173-24-7 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity 30 is chemically 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile. Gefitinib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 675126-27-9
Purchase 675126-27-9
Order 675126-27-9
Enquire 675126-27-9
price of 675126-27-9
675126-27-9 Supplier
675126-27-9 Manufacturer
675126-27-9 Exporter
buy high quality Gefitinib Impurity 30
Purchase Gefitinib Impurity 30
Gefitinib Impurity 30 suppliers
Gefitinib Impurity 30 manufacturers
Gefitinib Impurity 30 price
Order Gefitinib Impurity 30
Enquire Gefitinib Impurity 30
Gefitinib Impurity 30 cost
Gefitinib Impurity 30 Supplier
Gefitinib Impurity 30 Distributor
Gefitinib Impurity 30 for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity 30 for ANDA Filing
Gefitinib Impurity 30 for Forced Degradation Studies
Gefitinib Impurity 30 Identification Standards
Gefitinib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


